5-Amino-1MQ Oral vs Injection: What Research Shows
By RUOcodes.com Research Team
Published:
5-Amino-1MQ oral vs injection: dose differences, bioavailability tradeoffs, and which route the research supports. Updated 2026.
5-Amino-1MQ is a small-molecule NNMT inhibitor—not a peptide. Published route data remain preclinical. 5-Amino-1MQ oral vs injection: the short answer 5-Amino-1MQ is not a peptide. It is a small molecule, so the claim that oral delivery must fail because digestive enzymes destroy peptide bonds does not apply. A rat pharmacokinetic study reported 38.4% absolute oral bioavailability, a peak plasma concentration of approximately 2,252 ng/mL, and a 6.9-hour terminal half-life after oral dosing, compared with 3.8 hours after intravenous administration. However, the animal efficacy studies used injection, and no published human pharmacokinetic, efficacy, or head-to-head route trial has established which route performs better in people. Why is 5-Amino-1MQ not actually a peptide? 5-Amino-1MQ , or 5-amino-1-methylquinolinium, is often listed beside research peptides such as BPC-157 , Ipamorelin , and Semax . That catalog placement has created a persistent misconception about how the compound behaves when taken orally. 5-Amino-1MQ is a small molecule with a molecular mass of about 159 daltons and a quinolinium ring structure. It has no peptide bonds for pepsin, trypsin, or chymotrypsin to cut. By comparison, BPC-157 is approximately 1,419 daltons, while insulin is roughly 5,800 daltons. This distinction changes the oral-delivery question. Researchers should ask whether 5-Amino-1MQ crosses the intestinal wall, whether transporters pump it back into the gut, how much reaches systemic circulation, and whether first-pass metabolism changes exposure. The absence of peptide bonds removes the proteolytic-digestion objection; it does not prove that every oral dose reaches circulation unchanged. How does 5-Amino-1MQ inhibit NNMT? 5-Amino-1MQ is studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide. Nicotinamide is also a precursor used to synthesize NAD+…
← Back to Blog